Brain abscesshematogenous transmission from a distant inflammatory deposit (chronic bronchitis, bronchiectasis and lung abscess, infectious endocarditis, in a young patient it can be HIV infection, immunodeficiency or drug abuse)
Uncharacteristic, blood culture often negative, there may be leukocytosis in the blood count, CSF examination is abnormal in 90% of cases, but uncharacteristic.
Therapy
Microbiological examination of the puncture and subsequent targeting of ATB treatment is important, samples are sent for examination for aerobic and anaerobic cultures, fungal and TB (tuberculosis) examinations.
Surgical treatment
Puncture of the abscess and suction of its contents. In the case of a large abscess on the surface of the brain, open resection (including capsule)
The capsule is a barrier preventing the achievement of effective ATB concentrations within the abscess → ATB treatment
ATB treatment
Long-term, 2–4 months, with the intravenous phase lasting 6 weeks, the effect of treatment is checked by repeated CT examinations.
Lethality
Today, the lethality is around 10%. Neurological deficit or epilepsy persists in 30% of patients after successful treatment.